Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials

MeSH terms

• Antibodies, Monoclonal, Humanized / therapeutic use*
• Clinical Trials, Phase III as Topic
• Dermatologic Agents / therapeutic use*
• Humans
• Pain / diagnosis
• Pain / drug therapy*
• Pain / psychology
• Pruritus / diagnosis
• Pruritus / drug therapy*
• Pruritus / psychology
• Psoriasis / diagnosis
• Psoriasis / drug therapy*
• Psoriasis / psychology
• Quality of Life
• Randomized Controlled Trials as Topic
• Remission Induction
• Severity of Illness Index
• Time Factors
• Treatment Outcome